Learn more about the exciting field of intratumoral immunotherapy and OncoSec’s role as a key leader in this emerging space.
Watch the Video
OncoSec to Present at Investment Conferences in January
OncoSec Announces First Quarter Financial Results for Fiscal Year
OncoSec to Present at the 9th Annual LD Micro Main Event
OncoSec Announces Key Corporate Initiatives at Inaugural Investor & Analyst Day on November 17, 2016
January 7 | San Francisco, CA
2017 East/West CEO Conference
January 11 | San Francisco, CA
9th Annual Conference Biotech Showcase
Our core technology platform continues to advance through clinical trials for various cancers.
The ImmunoPulse® platform is designed to boost the immune system to recognize and attack tumors.
OncoSec continues to establish relationships with industry leaders to further advance our research.
PDF | 2.0 MB
PDF | 1.0 MB